↓ Skip to main content

Dental implant surgery in patients in treatment with the anticoagulant oral rivaroxaban

Overview of attention for article published in Clinical Oral Implants Research, June 2015
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age
  • Above-average Attention Score compared to outputs of the same age and source (59th percentile)

Mentioned by

twitter
1 X user
facebook
1 Facebook page

Citations

dimensions_citation
50 Dimensions

Readers on

mendeley
80 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Dental implant surgery in patients in treatment with the anticoagulant oral rivaroxaban
Published in
Clinical Oral Implants Research, June 2015
DOI 10.1111/clr.12653
Pubmed ID
Authors

Gerardo Gómez-Moreno, Antonio Aguilar-Salvatierra, Esther Fernández-Cejas, Rafael Arcesio Delgado-Ruiz, Aleksa Markovic, José Luis Calvo-Guirado

Abstract

The aim of this study was to evaluate the incidence of bleeding complications after dental implant placement in patients in treatment by the anticoagulant oral rivaroxaban without interrupting its administration or modifying dosage. About 57 patients were divided into two groups: 18 had been in treatment by rivaroxaban for over 6 month before implant surgery and a control group consisted of 39 healthy subjects. All subjects received dental implants in different positions, without interrupting or modifying rivaroxaban dosage. Patients were treated in an outpatient setting. Non-absorbable sutures were used, and all patients were given gauze impregnated with tranexamic acid 5%, to bite on for 30-60 min. One rivaroxaban patient presented moderate bleeding the day after surgery, and two control patients presented moderate bleeding the day after and on the second day. Bleeding was managed with gauzes impregnated with tranexamic acid. No statistically significant differences (P = 0.688) were found in relation to bleeding episodes between the groups, with a relative risk = 0.919 based on the pooled groups and 95% confidence interval of 0.078-10.844. Dental implant surgery in patients taking the anticoagulant oral rivaroxaban can be performed safely in outpatients departments applying local hemostatic measures without the need to modify or interrupt anticoagulant medication.

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 80 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Slovenia 1 1%
Unknown 79 99%

Demographic breakdown

Readers by professional status Count As %
Student > Master 11 14%
Student > Bachelor 7 9%
Researcher 6 8%
Student > Doctoral Student 6 8%
Student > Postgraduate 6 8%
Other 16 20%
Unknown 28 35%
Readers by discipline Count As %
Medicine and Dentistry 39 49%
Agricultural and Biological Sciences 2 3%
Biochemistry, Genetics and Molecular Biology 1 1%
Immunology and Microbiology 1 1%
Economics, Econometrics and Finance 1 1%
Other 6 8%
Unknown 30 38%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 28 June 2016.
All research outputs
#16,107,597
of 24,508,104 outputs
Outputs from Clinical Oral Implants Research
#640
of 1,219 outputs
Outputs of similar age
#150,328
of 268,694 outputs
Outputs of similar age from Clinical Oral Implants Research
#18
of 49 outputs
Altmetric has tracked 24,508,104 research outputs across all sources so far. This one is in the 32nd percentile – i.e., 32% of other outputs scored the same or lower than it.
So far Altmetric has tracked 1,219 research outputs from this source. They receive a mean Attention Score of 2.8. This one is in the 45th percentile – i.e., 45% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 268,694 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 40th percentile – i.e., 40% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 49 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 59% of its contemporaries.